shanghaishanghai

#### 中新网兰州7月7日电 (戴文昌)

在一片繁荣与希望的氛围中,2024兰州高质量发展暨第三十届兰洽会兰州市重点招商引资项目集中签约活动于今日在兰州拉开帷幕。作为本次活动的亮点之一,iPS“造血工厂”与国家级细胞标本库项目的“牵手”标志着兰州高新区在生物技术领域又迈出了一大步,为兰州乃至甘肃的高质量发展注入了新的活力。

#### iPS“造血工厂”与国家级细胞标本库的“牵手”,不仅展示了兰州高新区在生物医药产业的前瞻布局,也体现了政府对创新和科技驱动经济发展的高度重视。此次合作将充分发挥双方在技术、资源和市场方面的优势,共同探索细胞治疗、再生医学等前沿领域的应用,推动兰州乃至全国的生物医药产业迈向国际前沿。

#### iPS“造血工厂”作为专注于诱导多能干细胞技术的领先企业,其在干细胞研究和应用领域的深厚积累,将为国家级细胞标本库的建设和运营提供强大支持。而国家级细胞标本库作为国家层面的重要生物资源平台,其丰富的细胞资源和研究基础,将为iPS“造血工厂”的技术创新和产品开发提供宝贵的数据和样本支持。

#### 双方的合作不仅将促进科研成果的转化,加速生物医药新技术的落地应用,还将对提升兰州高新区的科技创新能力、增强区域经济竞争力产生深远影响。通过这一合作,兰州高新区有望成为国内乃至国际生物医药领域的重要创新中心,为推动健康产业的发展、提高人民健康水平做出积极贡献。

#### 此次合作的签约,不仅是一次产业联盟的建立,更是兰州高新区在打造创新生态、推动高质量发展道路上迈出的坚实一步。随着更多创新资源的汇聚和合作项目的推进,兰州高新区将在生物医药、生物科技等领域展现出更强的发展潜力和国际竞争力。

#### 总之,iPS“造血工厂”与国家级细胞标本库的“牵手”签约,是兰州高新区在科技创新与产业融合方面的一次重要突破,为兰州乃至全国的生物医药产业高质量发展注入了新的动力,展示了兰州高新区在创新驱动发展战略中的积极姿态和广阔前景。

英语如下:

### New Highlights in Technology Cooperation: iPS ‘Blood Factory’ Partners with National Cell Repository in Lanzhou High-tech Zone

#### July 7, 2024 – China News Service (Translated)

Under the backdrop of a vibrant and promising atmosphere, the集中 signing ceremony of key investment and financing projects in Lanzhou for high-quality development and the 30th Lanzhou International Trade Fair kicked off in Lanzhou today. One of the highlights of this event is the partnership between the iPS ‘Blood Factory’ and the national cell repository, marking a significant step forward for Lanzhou High-tech Zone in the biotechnology sector and injecting new vigor into the high-quality development of Lanzhou and Gansu Province.

#### The partnership between the iPS ‘Blood Factory’ and the national cell repository not only showcases Lanzhou High-tech Zone’s forward-looking planning in the biopharmaceutical industry but also reflects the government’s high regard for innovation and the driving role of science and technology in economic development. This collaboration leverages the strengths of both parties in terms of technology, resources, and market to jointly explore applications in cutting-edge fields such as cell therapy and regenerative medicine, propelling the biopharmaceutical industry in Lanzhou and across China towards the forefront of the international scene.

#### As a leading enterprise in induced pluripotent stem cell technology, the iPS ‘Blood Factory’, with its deep expertise in stem cell research and applications, will provide substantial support for the construction and operation of the national cell repository. The rich cell resources and research foundation of the national cell repository, as a key biological resource platform at the national level, will offer invaluable data and sample support for the technological innovation and product development of the iPS ‘Blood Factory’.

#### This partnership not only facilitates the conversion of research outcomes and accelerates the application of biopharmaceutical new technologies but also has a profound impact on enhancing the innovation capabilities of Lanzhou High-tech Zone and strengthening its regional economic competitiveness. Through this collaboration, Lanzhou High-tech Zone is expected to become a significant center for innovation in the biopharmaceutical and biotechnology sectors, contributing positively to the development of the health industry and improving public health standards.

#### This signing ceremony is not merely an establishment of an industrial alliance but a solid step forward for Lanzhou High-tech Zone in its journey towards fostering an innovative ecosystem and driving high-quality development. With the gathering of more innovative resources and the advancement of collaborative projects, Lanzhou High-tech Zone is poised to exhibit stronger development potential and international competitiveness in the biopharmaceutical and biotechnology sectors.

#### In summary, the partnership between the iPS ‘Blood Factory’ and the national cell repository signifies an important breakthrough for Lanzhou High-tech Zone in the areas of scientific innovation and industry integration, injecting new momentum into the high-quality development of biopharmaceutical industries in Lanzhou and across the country. It showcases Lanzhou High-tech Zone’s proactive stance and broad prospects in the strategic development of innovation-driven.

【来源】http://www.chinanews.com/cj/2024/07-07/10247320.shtml

Views: 2

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注